All News #Library
Others
Accurar`s AC699 Monotherapy Phase 1 Data In ER+/HER2- Breast Cancer
01 Jun 2024 //
BUSINESSWIRE
Accutar Announces First Patient Dosed in China with AC0682 in PhI Study
11 Oct 2022 //
BUSINESSWIRE
Accutar Receives NMPA Clearance of IND Application for AC0176
19 Aug 2022 //
BUSINESSWIRE
FDA Grants FTD to Accutar`s AC0176 for mCRPC
01 Jun 2022 //
BIOSPACE
Accutar Biotechnology Receives NMPA Clearance of IND Application for AC0682
01 Apr 2022 //
BUSINESSWIRE
Accutar Bio Announces First Patient Dosed with AC0176 in Phase 1 Study in mCRPC
30 Mar 2022 //
BUSINESSWIRE

Market Place
Sourcing Support